Cochlear buys hearing implant rival Oticon Medical
Hearing implant manufacturer Cochlear will buy competitor Oticon Medical for $170 million following a decision by its parent company Demant to exit hearing implants business activities. Cochlear has committed to providing ongoing support for Oticon Medical’s base of more than 75,000 hearing implant recipients, which includes cochlear and acoustic implants. Cochlear CEO Dig Howitt said:…